1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Sarcoma 180 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braquet, P; Ishii, S; Karasawa, K; Nojima, S; Nozaki, T; Oda, K; Sasaki, T; Satoh, N; Senda, M; Setaka, M; Tohyama, T; Toyama, H | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Sarcoma 180
Article | Year |
---|---|
A distribution study of 11C platelet-activating factor (PAF) analogs in normal and tumor-bearing mice.
Topics: Animals; Carbon Radioisotopes; Kinetics; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reference Values; Sarcoma 180; Stereoisomerism; Tissue Distribution | 1996 |